1. Home
  2. RVP vs KALA Comparison

RVP vs KALA Comparison

Compare RVP & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Retractable Technologies Inc.

RVP

Retractable Technologies Inc.

HOLD

Current Price

$0.67

Market Cap

20.9M

Sector

Health Care

ML Signal

HOLD

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

HOLD

Current Price

$0.66

Market Cap

21.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVP
KALA
Founded
1994
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.9M
21.8M
IPO Year
2000
2017

Fundamental Metrics

Financial Performance
Metric
RVP
KALA
Price
$0.67
$0.66
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$31.50
AVG Volume (30 Days)
16.2K
183.8K
Earning Date
05-14-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
67.39
EPS
N/A
N/A
Revenue
$38,266,211.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
15.78
N/A
52 Week Low
$0.60
$0.07
52 Week High
$1.14
$20.58

Technical Indicators

Market Signals
Indicator
RVP
KALA
Relative Strength Index (RSI) 41.97 28.20
Support Level $0.66 $0.55
Resistance Level $0.74 $0.72
Average True Range (ATR) 0.02 0.13
MACD -0.00 -0.02
Stochastic Oscillator 1.77 8.54

Price Performance

Historical Comparison
RVP
KALA

About RVP Retractable Technologies Inc.

Retractable Technologies Inc is engaged in the manufacturing and marketing of safety medical products (predominantly syringes) for the healthcare industry. It has manufacturing facilities in Little Elm, Texas, and uses manufacturers in China as well. Its syringes are well-suited for administering vaccinations. The company's products are VanishPoint Syringe, VanishPoint Insulin Syringes, EasyPoint Needle, EasyPoint Blood Collection Tube with Needle, VanishPoint Blood Collection Set, and VanishPoint IV Catheter. It provides solutions such as Insulin, Immunization, Blood Collection, Allergy, General Purpose, and Infusion.

About KALA KALA BIO Inc.

Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Share on Social Networks: